# Chewed Versus Integral Pill of Ticagrelor

> **NCT03708588** · PHASE4 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 112 (actual)

## Conditions studied

- Percutaneous Coronary Intervention

## Interventions

- **DRUG:** Ticagrelor
- **DRUG:** Ticagrelor

## Key facts

- **NCT ID:** NCT03708588
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-19
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-07-31
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2024-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03708588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03708588, "Chewed Versus Integral Pill of Ticagrelor". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03708588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*